FDAHEALTHNEWS.COM: Keyword Density Checker

Total words: 2377 | 2-word phrases: 612 | 3-word phrases: 678 | 4-word phrases: 720

PAGE INFO

Title	Try to keep the title under 60 characters (15 characters) FDA Health News
Description	Try to keep the meta description between 50 - 160 characters (325 characters) FDA Health News covers the U.S. Food and Drug Administration's Center for Drug Evaluation and Research and its Center for Devices and Radiological Health. It reports on the FDA's process of testing and approving new drugs, its interactions with pharmaceutical companies, and any other news related to the FDA.
Keywords	Meta keywords are not recommended anymore (325 characters) FDA Health News
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	press release submissionjan	9	1.33%
2	by press release	8	1.18%
3	the treatment of	8	1.18%
4	for the treatment	8	1.18%
5	release submissionjan 8	7	1.03%
6	submissionjan 8 2021	7	1.03%
7	fast track designation	5	0.74%
8	fda health news	5	0.74%
9	the fda for	4	0.59%
10	the us food	4	0.59%
11	us food and	4	0.59%
12	of phase 2	3	0.44%
13	end of phase	3	0.44%
14	track designation for	3	0.44%
15	associated with pyridoxamine	3	0.44%
16	with pyridoxamine 5phosphate	3	0.44%
17	pyridoxamine 5phosphate oxidase	3	0.44%
18	fda fast track	3	0.44%
19	arx788 fast track	3	0.44%
20	drug administration fda	3	0.44%
21	approval patients drug	3	0.44%
22	food and drug	3	0.44%
23	sarscov2 viral mutation	2	0.29%
24	of function gene	2	0.29%
25	function gene variants	2	0.29%
26	designation for her2positive	2	0.29%
27	fda issues alert	2	0.29%
28	pivotal phase 3	2	0.29%
29	clinical laboratory staff	2	0.29%
30	union therapeutics as	2	0.29%

#	Keyword	Frequency	Density
1	by press release submissionjan	8	1.11%
2	release submissionjan 8 2021	7	0.97%
3	for the treatment of	7	0.97%
4	press release submissionjan 8	7	0.97%
5	the us food and	4	0.56%
6	us food and drug	3	0.42%
7	with pyridoxamine 5phosphate oxidase	3	0.42%
8	associated with pyridoxamine 5phosphate	3	0.42%
9	fast track designation for	3	0.42%
10	end of phase 2	3	0.42%
11	fda fast track designation	3	0.42%
12	regarding sarscov2 viral mutation	2	0.28%
13	ind filing with fda	2	0.28%
14	macular degeneration amd in	2	0.28%
15	regulation by press release	2	0.28%
16	pyridoxamine 5phosphate oxidase pnpo	2	0.28%
17	complement factor h cfh	2	0.28%
18	factor h cfh loss	2	0.28%
19	h cfh loss of	2	0.28%
20	seizures associated with pyridoxamine	2	0.28%
21	filing with fda for	2	0.28%
22	cfh loss of function	2	0.28%
23	sarscov2 viral mutation to	2	0.28%
24	loss of function gene	2	0.28%
25	of function gene variants	2	0.28%
26	trial ind filing with	2	0.28%
27	food and drug administration	2	0.28%
28	3 trial ind filing	2	0.28%
29	phase 3 trial ind	2	0.28%
30	pivotal phase 3 trial	2	0.28%
31	viral mutation to health	2	0.28%
32	track designation for her2positive	2	0.28%
33	union therapeutics as receives	2	0.28%
34	arx788 fast track designation	2	0.28%
35	phase 2 meeting with	2	0.28%
36	designation for her2positive metastatic	2	0.28%
37	press release submissionjan 6	2	0.28%
38	release submissionjan 6 2021	2	0.28%
39	that the us food	2	0.28%
40	refractory cutaneous tcell lymphoma	2	0.28%

#	URL	Whois	Check